Androgenicity of the progestin in oral contraceptives does not affect maximal leg strength

Contraception

Volumn 74, Issue 6, 2006, Pages 487-491

  Peters, Charlotte ^a   Burrows, Melonie ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Contraception; Isokinetic; Levonorgestrel; Monophasic; Norgestimate

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORGESTIMATE; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ANDROGENESIS; ARTICLE; CONTRACEPTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LEG MUSCLE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; NORMAL HUMAN; TORQUE;

ADULT; ANDROGENS; CONTRACEPTIVES, ORAL, COMBINED; ETHINYL ESTRADIOL; EXERCISE; FEMALE; HUMANS; LEG; LEVONORGESTREL; MUSCLE STRENGTH; NORGESTREL; PROGESTERONE CONGENERS; PROGESTINS; SPORTS;

EID: 33845954989     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.08.005     Document Type: Article

References (20)

1. Bennell K., White S., and Crossley K. The oral contraceptive pill: a revolution for sportswomen?. Br J Sports Med 33 (1999) 231-238
2. Thorneycroft I.H. Update on androgenicity. Am J Obstet Gynecol 180 (1999) S288-S294
3. Van der Vange N., Blankenstein M.A., Kloosterboer H.J., Haspels A.A., and Thijssen J.H. Effects of seven low dose combined oral contraceptives on sex hormone binding globulin, corticosteroids binding globulin, total and free testosterone. Contraception 41 (1990) 345-352
4. Phillips S.K., Sanderson A.G., Birch K., Bruce S.A., and Woledge R.C. Changes in maximal voluntary force of human adductor pollicis muscle during the menstrual cycle. J Physiol 496 (1996) 551-557
5. Lebrun C.M., Petit M.A., McKenzie D.C., Taunton J.E., and Prior J.C. Decreased maximal aerobic capacity with the use of a triphasic oral contraceptive in highly active women: a randomised controlled trial. Br J Sports Med 37 (2003) 315-320
6. Redman L.M., and Weatherby R.P. Measuring performance during the menstrual cycle: a model using oral contraceptives. Med Sci Sports Exerc 36 (2004) 130-136
7. Sarwar R., Niclos B.B., and Rutherford O.M. Changes in muscle strength, relaxation rate and fatigability during the human menstrual cycle. J Physiol 493 (1996) 267-272
8. Elliot K.J., Cable N.T., and Reilly T. Does oral contraception use affect maximum force production in women?. Br J Sports Med 39 (2005) 15-19
9. Suhonen S., Haukkamaa M., Jakobsson T., and Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 69 (2004) 407-412
10. Coney P., Washenik K., Langley R.G.B., DiGiovanna J.J., and Harrison D.D. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception 63 (2001) 297-302
11. De Ste Croix M.B.A., Armstrong N., Welsman J.R., and Sharpe P. Longitudinal changes in isokinetic leg strength in 10-14-year-olds. Ann Hum Biol 29 (2002) 50-62
12. Bambaeichi E., Reilly T., Cable N.T., and Giacomoni M. The isolated and combined effects of menstrual cycle phase and time-of-day on muscle strength of eumenorrhoeic females. Chronobiol Int 21 (2004) 645-660
13. Baltzopoulos V., and Brodie D.A. Isokinetic dynamometry; applications and limitations. Sports Med 8 (1989) 101-116
14. Cramer J.T., Housh T.J., Weir J.P., et al. Gender, muscle, and velocity comparisons of mechanomyographic and electromyographic responses during isokinetic muscle actions. Scand J Med Sci Sports 14 (2004) 116-127
15. Petrosky J.S., LePonne D.M., and Rinehart J.S. Isometric strength and endurance during the menstrual cycle. Eur J Appl Physiol 35 (1976) 1-10
16. Ruzic L., Matkovic B.R., and Leko G. Antiandrogens in hormonal contraception limit muscle strength gain in strength training: comparison study. Croat Med J 44 (2003) 65-68
17. Giacomoni M., Bernard T., Gavarry O., Altare S., and Falgairette G. Influence of the menstrual cycle phase and menstrual symptoms on maximal anaerobic performance. Med Sci Sports Exerc 32 (2000) 486-492
18. Lynch N.J., De Vito G., and Nimmo M.A. Low dosage monophasic oral contraceptive use and intermittent exercise and metabolism in humans. Eur J Appl Physiol 84 (2001) 296-301
19. Phillips A., Demarest K., Hahn D.W., Wong F., and McGuire J.L. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins. Contraception 41 (1990) 399-410
20. Fotherby K. Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy. Contraception 54 (1996) 59-69